Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: January 22, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Enclomiphene

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Enclomiphene?

Enclomiphene is an investigational drug.

There have been 21 clinical trials for Enclomiphene. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2006.

The most common disease conditions in clinical trials are Hypogonadism, Neoplasm Metastasis, and Renal Insufficiency. The leading clinical trial sponsors are Repros Therapeutics Inc., Woman's Health University Hospital, Egypt, and Celerion.

Recent Clinical Trials for Enclomiphene
A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg EnclomipheneRepros Therapeutics Inc.Phase 2
Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary SyndromeWoman's Health University Hospital, EgyptPhase 2
Androxal in Male InfertilityBaylor College of MedicinePhase 2/Phase 3

See all Enclomiphene clinical trials

Clinical Trial Summary for Enclomiphene

Top disease conditions for Enclomiphene
Top clinical trial sponsors for Enclomiphene

See all Enclomiphene clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.